Prevention of early recurrence of spontaneous subarachnoid haemorrhage by epsilon-aminocaproic acid.
Chowdhary U M, Carey P C, Hussein M M·Lancet (London, England)
A controlled clinical trial of epsilon-aminocaproic acid (E.A.C.A.), 36 g/day, was undertaken to assess its effectiveness in reducing immediate recurrence in patients with spontaneous subarachnoid haemorrhage (S.A.H.) proved by lumbar puncture. Of 83 patients treated with E.A.C.A., 3 (4%) had recurrent haemorrhage, and…